GEHC · GE HealthCare Technologies Inc.
$70.31
+0.07 (+0.10%)
At close · Aug 6
Market Cap
$31.98B
Shares
454.89M
GE HealthCare Technologies Inc. Earnings Call Transcripts
Every quarterly earnings call for GE HealthCare Technologies Inc. (GEHC) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
·
$4.94B
$555.00M
'22 Q4
23-01-30
▲8.4%
$4.71B
$372.00M
'23 Q1
23-04-25
▲7.4%
$4.82B
$418.00M
'23 Q2
23-07-25
▲5.4%
$4.82B
$375.00M
'23 Q3
23-10-31
▲5.4%
$5.21B
$403.00M
'23 Q4
24-02-06
▼1.2%
$4.65B
$374.00M
'24 Q1
24-04-30
▲0.5%
$4.84B
$428.00M
'24 Q2
24-07-31
▲0.9%
$4.86B
$470.00M
'24 Q3
24-10-30
▲2.2%
$5.32B
$721.00M
'24 Q4
25-02-13
▲2.7%
$4.78B
$564.00M
'25 Q1
25-04-30
▲3.5%
$5.01B
$486.00M
'25 Q2
25-07-30
▲5.8%
$5.14B
$446.00M
'25 Q3
25-10-29
▲7.1%
$5.70B
$588.00M
'25 Q4
26-02-04
LATEST
▲7.4%
$5.13B
$389.00M
'26 Q1
26-04-29
Earnings call
FY26 · Q2
2026-07-29
GE HealthCare Second Quarter 2026 Earnings Conference Call
Confident tone
PCS business challenges and strategic review
Inflation and cost mitigation
AI productivity
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-03
Jefferies Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-29
GE HealthCare Technologies Inc. Q1 FY2026 Earnings Call
Cautious tone
Inflation and input cost pressure
Regional performance
Segment reorganization
Revenue
$5.13B
▲ 7.4% YoY Diluted EPS
$0.85
▼ 30.9% YoY Gross margin
38.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-04
GE HealthCare Technologies Inc. Q4 FY2025 Earnings Call
Confident tone
Order growth and backlog
China and VBP tender environment
2026 financial guidance and setup
Revenue
$5.70B*
▲ 7.1% YoY Gross margin
39.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-29
GE HealthCare Technologies Inc. Q3 FY2025 Earnings Call
Confident tone
Flyrcado product launch and ramp
Precision care strategy and innovation pipeline
Margin performance and operational improvements
Revenue
$5.14B
▲ 5.8% YoY Diluted EPS
$0.98
▼ 3.9% YoY Gross margin
38.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-30
GE HealthCare Technologies Inc. Q2 FY2025 Earnings Call
Confident tone
Capital equipment orders and backlog
Imaging segment
Tariff impact and mitigation
Revenue
$5.01B
▲ 3.5% YoY Diluted EPS
$1.06
▲ 14% YoY Gross margin
39.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-30
GE HealthCare Technologies Inc. Q1 FY2025 Earnings Call
Positive tone
Tariffs and trade environment
China and geographic dynamics
Cash flow and capital allocation
Revenue
$4.78B
▲ 2.7% YoY Diluted EPS
$1.23
▲ 51.9% YoY Gross margin
42.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-13
GE HealthCare Technologies Inc. Q4 FY2024 Earnings Call
Confident tone
2025 guidance and capital equipment outlook
Margin expansion and productivity
China market
Revenue
$5.32B*
▲ 2.2% YoY Gross margin
42.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-10-30
GE HealthCare Technologies Inc. Q3 FY2024 Earnings Call
Positive tone
China market headwinds
2024 guidance and Q4 outlook
Flyrcado (flurpiridaz) launch
Revenue
$4.86B
▲ 0.9% YoY Diluted EPS
$1.02
▲ 24.4% YoY Gross margin
41.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-31
GE HealthCare Technologies Inc. Q2 FY2024 Earnings Call
Positive tone
China market headwinds and guidance cut
Margin expansion and lean/Kaizen productivity
Full-year guidance on revenue, EPS, and free cash flow
Revenue
$4.84B
▲ 0.5% YoY Diluted EPS
$0.93
▲ 2.2% YoY Gross margin
41.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-04-30
GE HealthCare Technologies Inc. Q1 FY2024 Earnings Call
Positive tone
China market and stimulus
Margin expansion and productivity
Revenue and orders performance
Revenue
$4.65B
▼ 1.2% YoY Diluted EPS
$0.81
▲ 97.6% YoY Gross margin
40.9%
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-06
GE HealthCare Technologies Inc. Q4 FY2023 Earnings Call
Confident tone
Organic revenue growth and segment performance
Margin expansion and productivity
Backlog and orders momentum
Revenue
$5.21B*
▲ 5.4% YoY Gross margin
41.4%
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-31
GE HealthCare Technologies Inc. Q3 FY2023 Earnings Call
Revenue
$4.82B
▲ 5.4% YoY Diluted EPS
$0.82
▼ 23.4% YoY Gross margin
40.1%
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-25
GE HealthCare Technologies Inc. Q2 FY2023 Earnings Call
Revenue
$4.82B
▲ 7.4% YoY Diluted EPS
$0.91
▼ 15% YoY Gross margin
40.3%
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-25
GE HealthCare Technologies Inc. Q1 FY2023 Earnings Call
Revenue
$4.71B
▲ 8.4% YoY Diluted EPS
$0.41
▼ 52.3% YoY Gross margin
40.2%
Rev · 4q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-01-30
GE HealthCare Technologies Inc. Q4 FY2022 Earnings Call
Revenue
$4.94B*
Gross margin
39.1%
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Showing 1–16 of 16 earnings calls
Key facts
CIK
1932393
CUSIP
36266G107
13F (30d)
604 filings
571 filers
Visit website
Investor relations